Table 1.
Characteristics | Open (n = 59) | VATS (n = 26) | P |
---|---|---|---|
Age | 60.76 ± 9.90 | 64.31 ± 9.53 | 0.125 |
Gender (male) | 43 (72.9%) | 18 (69.2%) | 0.730 |
Tuberculosis history | 6 (10.2%) | 4 (15.4%) | 0.492 |
Smoking | 37 (62.7%) | 16 (61.5%) | 0.918 |
Pack‐year | 30.84 ± 18.63 | 36.13 ± 28.94 | 0.510 |
ECOG PS | 0.092 | ||
0 | 53 (89.8%) | 26 (100%) | |
1 | 6 (10.2%) | 0 | |
FVC (%) | 88.04 ± 15.73 | 86.36 ± 21.53 | 0.696 |
FEV1 (%) | 90.87 ± 19.03 | 91.27 ± 13.54 | 0.914 |
Tumor size (cm) | 4.24 ± 1.90 | 3.63 ± 1.56 | 0.164 |
Invasion to other structures | 16 (27.1%) | 2 (7.7%) | 0.043* |
Radiation dose (cGy) | 4942.80 ± 774.32 | 4757.50 ± 893.31 | 0.364 |
Location | 0.050 | ||
RUL | 14 (23.7%) | 11 (42.3%) | |
RML | 1 (1.7%) | 2 (7.7%) | |
RLL | 10 (16.9%) | 7 (26.9%) | |
LUL | 23 (39.0%) | 3 (11.5%) | |
LLL | 8 (13.6%) | 2 (7.7%) | |
> 2 lobes | 3 (5.1%) | 1 (3.8%) |
ECOG PS, Eastern Cooperative Oncology Group performance status; FEV1, forced expiratory volume after 1 second; FVC, forced vital capacity; LLL, left lower lobe; LUL, left upper lobe; NSCLC, non‐small cell lung cancer; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe; VATS, video‐assisted thoracoscopic surgery.
, statistically significant.